Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cartilage is a specialized connective tissue providing structural support, shock absorption, and friction reduction in joints and other locations. It is composed of chondrocytes embedded in an extracellular matrix (ECM) containing collagen, proteoglycans, and glycosaminoglycans. Different types of cartilage (hyaline, fibrocartilage, elastic) exist, each with distinct properties and locations. Cartilage's avascular nature limits its regenerative capacity, posing challenges for therapeutic intervention. Emerging therapies target specific ECM components like type II collagen to enhance drug delivery and promote cartilage repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage Tissue.